医用钛合金的微弧氧化膜层组织及其磨损性能
发布人：上海艾荔艾合金股份有限公司www.shailiai.cn
更新时间：2016-01-14
采用微弧氧化方法对医用钛合金表面进行改性，利用X射线衍射分析(XRD)、扫描电镜(SEM)对微弧氧化膜层的表面形貌和化学成分进行分析，通过小振幅往复摩擦磨损试验测量膜层的耐磨损性能。
医用钛合金的微弧氧化膜层组织及其磨损性能Microstructure and its wear property of micro-arc oxidation coating on biomedical titanium alloy采用微弧氧化方法对医用钛合金表面进行改性，利用X射线衍射分析(XRD)、扫描电镜(SEM)对微弧氧化膜层的表面形貌和化学成分进行分析，通过小振幅往复摩擦磨损试验测量膜层的耐磨损性能。结果表明：钛合金经过微弧氧化表面处理后，所得膜层存在不同尺寸的放电微孔，氧化膜内层相对外层较为致密；膜层主要由大量金红石型TiO2相、非晶相SiO2及少量锐钛矿型TiO2相组成；与基体相比，微弧氧化膜层的初期摩擦因数从0.7降低至0.1，耐磨性提高。
The coating prepared by micro-arc oxidation (MAO) on biomedical titanium alloy was investigated. The surface morphology and chemical composition of MAO coating were analyzed by X-ray diffractometry and scanning electron microscopy (SEM). The anti-wear property of the coating was measured through small amplitude oscillatory reciprocating friction and wear test. The results show that the MAO coating has some micropores with different dimensions and the inner layer of the coating is denser compared with the outer layer. The composition of the coating comprises majority of rutile TiO2 and amorphous phase SiO2. A fraction of the composition is anatase TiO2. The preliminary friction coefficient of the coating decreases from 0.7 to 0.1. The micro-arc oxidation treatment improves the anti-wear property of the titanium alloy.
作为值得信赖的合作伙伴和高品质金属合金的半成品供应商，艾荔艾拥有完善的服务体系和专业的团队。在同客户交易的过程中，我们力求根据不同的应用需求将我们的产品做到精益求精。针对当前和未来的市场需求，艾荔艾致力于为客户提供最佳的金属材料解决方案。
AILIAI has been a reliable partner and supplier of sophisticated and high-quality semi-finished products maed of alloys. In dialogue with our customers, we optimise our products to meet the specific application requirements. AILIAI develops the best alloy material solutions for current and future challenges.
获取更多我们供应的合金和服务信息，请致电086-021-67660801或发电子邮件kefu@ailiaigroup.com联系我们，您也可以通过微博，微信，领英和推特与我们互动。
For more information on the alloys and services that we supply, call us at 086-021-67660801 or email us at kefu@ailiaigroup.com. You can also get in touch on social media, we are constantly active on Weibo, Weixin, LinkedIn and Twitter.